Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

NCT03137888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Gliosarcoma

Interventions

RADIATION: Dose-Escalated Radiation Therapy
PROCEDURE: Spectroscopic Magnetic Resonance Imaging
DRUG: Temozolomide

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]